Product NDC: | 0002-3230 |
Proprietary Name: | Symbyax |
Non Proprietary Name: | Olanzapine and Fluoxetine hydrochloride |
Active Ingredient(s): | 25; 3 mg/1; mg/1 & nbsp; Olanzapine and Fluoxetine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0002-3230 |
Labeler Name: | Eli Lilly and Company |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021520 |
Marketing Category: | NDA |
Start Marketing Date: | 20070409 |
Package NDC: | 0002-3230-07 |
Package Description: | 7 CAPSULE in 1 BOTTLE (0002-3230-07) |
NDC Code | 0002-3230-07 |
Proprietary Name | Symbyax |
Package Description | 7 CAPSULE in 1 BOTTLE (0002-3230-07) |
Product NDC | 0002-3230 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Olanzapine and Fluoxetine hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20070409 |
Marketing Category Name | NDA |
Labeler Name | Eli Lilly and Company |
Substance Name | FLUOXETINE HYDROCHLORIDE; OLANZAPINE |
Strength Number | 25; 3 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |